IBDEI0XK ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16653,1,3,0)
 ;;=3^V25.13
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^Remove/Insert IUD
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^339687
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=V25.2^^108^1046^87
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16654,1,3,0)
 ;;=3^V25.2
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^Sterilization
 ;;^UTILITY(U,$J,358.3,16654,2)
 ;;=^114162
 ;;^UTILITY(U,$J,358.3,16655,0)
 ;;=V25.40^^108^1046^26
 ;;^UTILITY(U,$J,358.3,16655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16655,1,3,0)
 ;;=3^V25.40
 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
 ;;=4^Contracept Surveill
 ;;^UTILITY(U,$J,358.3,16655,2)
 ;;=^295348
 ;;^UTILITY(U,$J,358.3,16656,0)
 ;;=V25.41^^108^1046^25
 ;;^UTILITY(U,$J,358.3,16656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16656,1,3,0)
 ;;=3^V25.41
 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
 ;;=4^Contracept Pill Surveill
 ;;^UTILITY(U,$J,358.3,16656,2)
 ;;=^295349
 ;;^UTILITY(U,$J,358.3,16657,0)
 ;;=V25.42^^108^1046^51
 ;;^UTILITY(U,$J,358.3,16657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16657,1,3,0)
 ;;=3^V25.42
 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
 ;;=4^IUD Surveillance
 ;;^UTILITY(U,$J,358.3,16657,2)
 ;;=^295350
 ;;^UTILITY(U,$J,358.3,16658,0)
 ;;=V25.43^^108^1046^52
 ;;^UTILITY(U,$J,358.3,16658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16658,1,3,0)
 ;;=3^V25.43
 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
 ;;=4^Implant Contraceptive
 ;;^UTILITY(U,$J,358.3,16658,2)
 ;;=^295351
 ;;^UTILITY(U,$J,358.3,16659,0)
 ;;=V25.5^^108^1046^89
 ;;^UTILITY(U,$J,358.3,16659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16659,1,3,0)
 ;;=3^V25.5
 ;;^UTILITY(U,$J,358.3,16659,1,4,0)
 ;;=4^Subdermal Contraceptive
 ;;^UTILITY(U,$J,358.3,16659,2)
 ;;=^295352
 ;;^UTILITY(U,$J,358.3,16660,0)
 ;;=V26.51^^108^1046^91
 ;;^UTILITY(U,$J,358.3,16660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16660,1,3,0)
 ;;=3^V26.51
 ;;^UTILITY(U,$J,358.3,16660,1,4,0)
 ;;=4^Tubal Ligation Status
 ;;^UTILITY(U,$J,358.3,16660,2)
 ;;=^321178
 ;;^UTILITY(U,$J,358.3,16661,0)
 ;;=614.0^^108^1046^9
 ;;^UTILITY(U,$J,358.3,16661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16661,1,3,0)
 ;;=3^614.0
 ;;^UTILITY(U,$J,358.3,16661,1,4,0)
 ;;=4^Acute Salpingitis and Oophoritis
 ;;^UTILITY(U,$J,358.3,16661,2)
 ;;=^270465
 ;;^UTILITY(U,$J,358.3,16662,0)
 ;;=614.1^^108^1046^22
 ;;^UTILITY(U,$J,358.3,16662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16662,1,3,0)
 ;;=3^614.1
 ;;^UTILITY(U,$J,358.3,16662,1,4,0)
 ;;=4^Chr Salpingitis and Oophoritis
 ;;^UTILITY(U,$J,358.3,16662,2)
 ;;=^270466
 ;;^UTILITY(U,$J,358.3,16663,0)
 ;;=616.2^^108^1046^28
 ;;^UTILITY(U,$J,358.3,16663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16663,1,3,0)
 ;;=3^616.2
 ;;^UTILITY(U,$J,358.3,16663,1,4,0)
 ;;=4^Cyst of Bartholin Gland
 ;;^UTILITY(U,$J,358.3,16663,2)
 ;;=^12754
 ;;^UTILITY(U,$J,358.3,16664,0)
 ;;=616.3^^108^1046^5
 ;;^UTILITY(U,$J,358.3,16664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16664,1,3,0)
 ;;=3^616.3
 ;;^UTILITY(U,$J,358.3,16664,1,4,0)
 ;;=4^Abscess of Bartholin Gland
 ;;^UTILITY(U,$J,358.3,16664,2)
 ;;=^12748
 ;;^UTILITY(U,$J,358.3,16665,0)
 ;;=616.4^^108^1046^6
 ;;^UTILITY(U,$J,358.3,16665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16665,1,3,0)
 ;;=3^616.4
 ;;^UTILITY(U,$J,358.3,16665,1,4,0)
 ;;=4^Abscess of Vulva
 ;;^UTILITY(U,$J,358.3,16665,2)
 ;;=^270476
 ;;^UTILITY(U,$J,358.3,16666,0)
 ;;=617.0^^108^1046^40
 ;;^UTILITY(U,$J,358.3,16666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16666,1,3,0)
 ;;=3^617.0
 ;;^UTILITY(U,$J,358.3,16666,1,4,0)
 ;;=4^Endometriosis of Uterus
